153 related articles for article (PubMed ID: 11498515)
1. Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997, in vivo.
Hayashi I; Ishihara K; Kumagai Y; Majima M
Br J Pharmacol; 2001 Aug; 133(8):1296-306. PubMed ID: 11498515
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.
Asano M; Hatori C; Sawai H; Johki S; Inamura N; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Mizutani T; Oku T; Nakahara K
Br J Pharmacol; 1998 Jun; 124(3):441-6. PubMed ID: 9647466
[TBL] [Abstract][Full Text] [Related]
3. Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
Griesbacher T; Legat FJ
Br J Pharmacol; 1997 Mar; 120(5):933-9. PubMed ID: 9138701
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
5. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
[TBL] [Abstract][Full Text] [Related]
6. FR190997, a novel bradykinin B2 agonist, expresses longer action than bradykinin in paw edema formation and hypotensive response.
Ueno A; Naraba H; Kojima F; Morita E; Oh-ishi S
Immunopharmacology; 1999 Dec; 45(1-3):89-93. PubMed ID: 10614995
[TBL] [Abstract][Full Text] [Related]
7. Mouse paw edema induced by a novel bradykinin agonist and its inhibition by B2-antagonists.
Ueno A; Naraba H; Oh-ishi S
Jpn J Pharmacol; 1998 Sep; 78(1):109-11. PubMed ID: 9804073
[TBL] [Abstract][Full Text] [Related]
8. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
[TBL] [Abstract][Full Text] [Related]
9. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
10. Nonpeptide mimic of bradykinin with long-acting properties.
Aramori I; Zenkoh J; Morikawa N; Asano M; Hatori C; Sawai H; Kayakiri H; Satoh S; Inoue T; Abe Y; Sawada Y; Mizutani T; Inamura N; Iwami M; Nakahara K; Kojo H; Oku T; Notsu Y
Immunopharmacology; 1999 Dec; 45(1-3):185-90. PubMed ID: 10615010
[TBL] [Abstract][Full Text] [Related]
11. Nonpeptide mimic of bradykinin with long-acting properties at the bradykinin B2 receptor.
Aramori I; Zenkoh J; Morikawa N; Asano M; Hatori C; Sawai H; Kayakiri H; Satoh S; Inoue T; Abe Y; Sawada Y; Mizutani T; Inamura N; Nakahara K; Kojo H; Oku T; Notsu Y
Mol Pharmacol; 1997 Jul; 52(1):16-20. PubMed ID: 9224807
[TBL] [Abstract][Full Text] [Related]
12. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
[TBL] [Abstract][Full Text] [Related]
13. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
[TBL] [Abstract][Full Text] [Related]
14. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
[TBL] [Abstract][Full Text] [Related]
15. 5-hydroxytryptamine release from skin mast cells in vivo induced by peptide but not by nonpeptide ligands for bradykinin receptors.
Griesbacher T; Rainer I
Immunopharmacology; 1999 Sep; 43(2-3):195-201. PubMed ID: 10596853
[TBL] [Abstract][Full Text] [Related]
16. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
[TBL] [Abstract][Full Text] [Related]
17. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.
Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K
Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139
[TBL] [Abstract][Full Text] [Related]
18. A nonpeptide mimic of bradykinin blunts the development of hypertension in young spontaneously hypertensive rats.
Majima M; Hayashi I; Inamura N; Fujita T; Ogino M
Hypertension; 2000 Jan; 35(1 Pt 2):437-42. PubMed ID: 10642338
[TBL] [Abstract][Full Text] [Related]
19. Blockade of bradykinin B(2) receptor suppresses acute pancreatitis induced by obstruction of the pancreaticobiliary duct in rats.
Hirata M; Hayashi I; Yoshimura K; Ishii K; Soma K; Ohwada T; Kakita A; Majima M
Br J Pharmacol; 2002 Jan; 135(1):29-36. PubMed ID: 11786477
[TBL] [Abstract][Full Text] [Related]
20. Effects of an orally active non-peptide bradykinin B2 receptor antagonist, FR173657, on plasma exudation in rat carrageenin-induced pleurisy.
Majima M; Kawashima N; Hiroshi I; Katori M
Br J Pharmacol; 1997 Jun; 121(4):723-30. PubMed ID: 9208140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
